The only human cathelicidin antimicrobial peptide, playing key roles in innate immune defense, wound healing, and modulation of inflammatory responses.
mBio|2013|Napier B et al.|71 citations
The alarming rise in antibiotic resistance has led to an increase in patient mortality and health care costs. This problem is compounded by the absence of new antibiotics close to regulatory approval. Acinetobacter baumannii is a human pathogen that…
PMID: 23695834
Research in microbiology|2013|Hein-Kristensen L et al.|15 citations
Antimicrobial peptides (AMPs) are promising leads for novel antibiotics; however, their activity is often compromised under physiological conditions. The purpose of this study was to determine the activity of α-peptide/β-peptoid peptidomimetics and A…
PMID: 23994143
Biomolecules & therapeutics|2013|Park K, Lee S, Lee Y|26 citations
Inflammatory skin diseases such as atopic dermatitis (AD) and rosacea were complicated by barrier abrogation and deficiency in innate immunity. The first defender of epidermal innate immune response is the antimicrobial peptides (AMPs) that exhibit a…
Review
PMID: 24244808
Peptides|2013|Jiang W et al.|48 citations
LL-37 is the single cathelicidin host defense peptide in humans with direct antimicrobial and immunomodulatory activities. Specific regulation of LL-37 synthesis has emerged as a novel non-antibiotic approach to disease control and prevention. Short-…
PMID: 24140860
Clinical immunology (Orlando, Fla.)|2013|Castañeda-Delgado J et al.|26 citations
There is an increased susceptibility to infections during elderly, mainly because of the decreased efficacy of adaptive immunity to contain microorganisms. Albeit most of the elderly adults develop this deficiency in adaptive immunity only a minor pe…
PMID: 23770629
Allergy|2013|Sun J et al.|33 citations
BACKGROUND: Eosinophils and their products, including leukotrienes and eosinophil cationic protein (ECP), are well-known mediators of inflammation and tissue damage in asthma. The antimicrobial peptide LL-37 exhibits a variety of immunomodulatory act…
PMID: 23330796
Immunology|2013|Klug-Micu G et al.|68 citations
The ability of T cells to activate antimicrobial pathways in infected macrophages is essential to host defence against many intracellular pathogens. Here, we compared the ability of two T-cell-mediated mechanisms to trigger antimicrobial responses ag…
Clinical Trial
PMID: 23289765
Cellular immunology|2013|Wang Q et al.|12 citations
Vitamin D and its metabolites have been recognized as key determinants in innate immune modulation. In this study, we investigated the regulation of antibacterial functions of oral keratinocyte cells by 25-hydroxyvitamin D3 (25VD3). OKF6/TERT2 cells,…
In Vitro
PMID: 23850962
mBio|2013|Okumura C et al.|27 citations
UNLABELLED: The Mac/IdeS protein of group A Streptococcus (GAS) is a secreted cysteine protease with cleavage specificity for IgG and is highly expressed in the GAS serotype M1T1 clone, which is the serotype most frequently isolated from patients wit…
Animal Study
PMID: 23900173
Biopolymers|2013|Juba M et al.|21 citations
Cationic antimicrobial peptides (CAMPs) represent an ancient defense mechanism against invading bacteria, with peptides such as the cathelicidins being essential elements of vertebrate innate immunity. CAMPs are typically associated with broad-spectr…
PMID: 23532931
Frontiers in immunology|2013|Duplantier A, van Hoek M|182 citations
Diabetic patients often have ulcers on their lower-limbs that are infected by multiple biofilm-forming genera of bacteria, and the elimination of the biofilm has proven highly successful in resolving such wounds in patients. To that end, antimicrobia…
PMID: 23840194
RSC advances|2013|Mishra B et al.|44 citations
Cationic antimicrobial peptides are recognized templates for developing a new generation of antimicrobials to combat superbugs. Human cathelicidin LL-37 is an essential host defense molecule in human innate immunity. Previously, we identified KR-12 a…
PMID: 24307932
Zhonghua zhong liu za zhi [Chinese journal of oncology]|2013|Li D et al.
OBJECTIVE: The aim of this study was to investigate the role of macrophages in promotion of ovarian tumor cell proliferation mediated by over-expression of antimicrobial peptide LL-37. METHODS: To co-culture ovarian tumor cells SKOV3, 3AO and HO-8910…
PMID: 24332052
F1000Research|2013|Paranjape S et al.|12 citations
BACKGROUND: Host-derived (LL-37) and synthetic (WLBU-2) cationic antimicrobial peptides (CAPs) are known for their membrane-active bactericidal properties. LL-37 is an important mediator for immunomodulation, while the mechanism of action of WLBU-2 r…
Animal Study
PMID: 24555033
PloS one|2013|Ye Y et al.|30 citations
OBJECTIVE: This prospective study evaluated clinical risk indicators as well as pro- and anti- inflammatory mediators at the time of malignancy diagnosis in relation to chemotherapy-related oral mucositis in pediatric population. METHODS: Patients (n…
PMID: 23741421
Journal of periodontology|2013|Suphasiriroj W et al.|17 citations
BACKGROUND: The antimicrobial peptide LL-37 is known to have a potent lipopolysaccharide (LPS)-neutralizing activity in various cell types. Because of observed heterogeneity within periodontopathogenic LPS, the authors hypothesized that LL-37 had spe…
PMID: 22443521
Fish & shellfish immunology|2013|Heinecke R, Buchmann K|48 citations
At hatching, the immune system of the rainbow trout larva is not fully developed. The larva emerges from the egg and is exposed to the aquatic freshwater environment containing pathogenic organisms. At this early stage, protection from disease causin…
PMID: 23261502
PloS one|2013|Thomassin J et al.|23 citations
Enteropathogenic and enterohemorrhagic Escherichia coli (EPEC and EHEC) are food-borne pathogens that colonize the small intestine and colon, respectively. To cause disease, these pathogens must overcome the action of different host antimicrobial pep…
PMID: 24324796
PloS one|2013|Currie S et al.|144 citations
Respiratory syncytial virus is a leading cause of lower respiratory tract illness among infants, the elderly and immunocompromised individuals. Currently, there is no effective vaccine or disease modifying treatment available and novel interventions…
In Vitro
PMID: 24023689
Gene therapy|2013|Ahluwalia A, Tarnawski A|5 citations
PMID: 22456327